Chandra Bhagat Pharma
CBPLBSE

Chandra Bhagat Pharma

₹49.900.00 (0.00%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
49.90
Today’s high
50.00
52 week low
29.70
52 week high
59.00
Open price
50.00
Previous close
49.90
Live volume
--
Lower circuit
47.41
Upper circuit
52.39

Fundamentals

Market Cap
₹38Cr
ROE
9.20%
P/E Ratio(TTM)
12.35
EPS(TTM)
4.04
P/B Ratio
1.14
Dividend Yield
0.00%
Industry P/E
50.37
Book Value
43.90
Debt to Equity
0.50
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
2026
Revenue (Cr)
₹120
+29.69%
Profit (Cr)
₹3.05
+255.11%
025100225400
2022
2023
2024
2025
2026
Revenue growthValue
3Y CAGR0%
Profit growthValue
3Y CAGR+50%

About

Chandra Bhagat Pharma Limited is primarily involved in the ethical marketing of pharmaceutical formulations and products for critical diseases. The company operates as a life-saving medicines provider, offering essential critical care products to patients across the globe. It has established a presence in major therapeutic categories including Anti-cancer (Oncology), Antibiotics, Anesthesia, Hormones, and Orthopedics. The company gets its approved formulations manufactured through contract manufacturers, supplying them to healthcare institutions, governments, and hospitals. Additionally, it is engaged in promoting and marketing Active Pharmaceuticals Ingredients (API's) within India. For the year under review, the net profit after tax grew to ₹153.02 lacs compared to ₹90.54 lacs in the previous year.;
CEO/MD
Hemant Chandravadan Bhagat
Founded in
2003
BSE symbol
542934

Shareholding pattern

Mar '24
Sep '24
Mar '25
Sep '25
Mar '26
Shareholder details

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
PfizerPFIZER
₹4,893.20
-85.00 (1.71%)
L
    H
    22,759.9530.965.42
    ₹2,504.00
    -56.80 (2.22%)
    L
      H
      19,444.5528.685.42
      ₹7,238.50
      -177.00 (2.39%)
      L
        H
        18,526.25109.2221.23
        Natco PharmaNATCOPHARM
        ₹885.00
        +2.60 (0.29%)
        L
          H
          15,806.4513.811.71
          2026
          25
          May
          Annual Result
          Release date
          2025
          13
          Nov
          Result
          Release date
          Events calendar
          View upcoming events in other stocks